ARTICLE | Financial News
Cleveland BioLabs planning follow-on
October 19, 2012 1:28 AM UTC
Cleveland BioLabs Inc. (NASDAQ:CBLI) said late Thursday it is planning a follow-on underwritten by Oppenheimer; Cantor Fitzgerald; and Ladenburg Thalmann. Cleveland BioLabs is developing CBLB502 for a...